<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629769</url>
  </required_header>
  <id_info>
    <org_study_id>1103 / 2016</org_study_id>
    <nct_id>NCT03629769</nct_id>
  </id_info>
  <brief_title>Effects of Proxelan Somministration in Patients With Chronic Prostatitis</brief_title>
  <official_title>Effects of Proxelan Somministration in Patients With Chronic Prostatitis Cat. IIa NIH: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pisa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a
      cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical
      prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI
      questionnaire items, spermatozoa motility/concentration variations and the semen cytokines
      level decrease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 16, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>National Institutes of Health - Chronic Prostatitis Symptom (NIH-CPS) questionnaires score</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluation of pain symptoms trough NIH-CPS questionnaires' pain items (0-6). Values from 0 to 3 normal/slight symptoms; Values from 3 to 6 moderate symptoms; Values over 6 severe symptoms.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Prostatitis</condition>
  <condition>Chronic Prostatitis With Chronic Pelvic Pain Syndrome</condition>
  <condition>Premature Ejaculation</condition>
  <arm_group>
    <arm_group_label>Patients with prostatitis-like symptoms</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cohort of patients with CP/CPPS (abacterial prostatitis)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Proxelan</intervention_name>
    <description>Administration of one suppository of proxelan once a day for 30 days</description>
    <arm_group_label>Patients with prostatitis-like symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - prostatitis like symptoms for at least three months

        Exclusion Criteria:

          -  significant post-voidal residual volume

          -  Meares and Stamey test suggestive for bacterial infection

          -  neoplasms,

          -  urinary stones,

          -  antibiotic therapy in the previous three months,

          -  irritable bowel syndrome,

          -  previous radiotherapic or chemiotherapic treatment,

          -  urethral stenosis,

          -  neurogenic bladder

          -  previous prostatic surgery
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AOUP Ospedale cisanello</name>
      <address>
        <city>Pisa</city>
        <state>Toscana</state>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Di Vico, MD</last_name>
      <phone>3393642655</phone>
      <email>urologiapisa@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Galeone G, Spadavecchia R, Balducci MT, Pagliarulo V. [The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial]. Minerva Urol Nefrol. 2012 Jun;64(2):135-41. Italian.</citation>
    <PMID>22617307</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>May 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>August 12, 2018</last_update_submitted>
  <last_update_submitted_qc>August 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pisa</investigator_affiliation>
    <investigator_full_name>Prof. Riccardo Bartoletti</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Prostate inflammation</keyword>
  <keyword>CPS/CPPS</keyword>
  <keyword>Prostatitis</keyword>
  <keyword>Proxelan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatitis</mesh_term>
    <mesh_term>Premature Ejaculation</mesh_term>
    <mesh_term>Pelvic Pain</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

